Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, January 31, 2022
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
[ Mon, Jan 31st 2022
] - WOPRAI
Sun, January 30, 2022
[ Sun, Jan 30th 2022
] - WOPRAI
[ Sun, Jan 30th 2022
] - WOPRAI
[ Sun, Jan 30th 2022
] - WOPRAI
[ Sun, Jan 30th 2022
] - WOPRAI
Fri, January 28, 2022
[ Fri, Jan 28th 2022
] - WOPRAI
[ Fri, Jan 28th 2022
] - WOPRAI
[ Fri, Jan 28th 2022
] - WOPRAI
Mani Foroohar Maintained (ALNY) at Hold with Increased Target to $109 on, Jan 28th, 2022
Mani Foroohar of SVB Leerink, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $108 to $109 on, Jan 28th, 2022.
Mani has made no other calls on ALNY in the last 4 months.
There are 9 other peers that have a rating on ALNY. Out of the 9 peers that are also analyzing ALNY, 0 agree with Mani's Rating of Hold.
These are the ratings of the 9 analyists that currently disagree with Mani
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $350 on, Thursday, January 20th, 2022
- David Lebowitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $215 on, Tuesday, January 18th, 2022
- Edward Tenthoff of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $208 on, Monday, January 3rd, 2022
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $205 on, Monday, November 22nd, 2021
- Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $273 on, Monday, November 22nd, 2021
- Luca Issi of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $225 on, Monday, November 22nd, 2021
- Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $200 on, Monday, November 1st, 2021
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $200 on, Friday, October 29th, 2021
- Esther Rajavelu of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $215 on, Monday, October 4th, 2021
